Tilray Brands, Inc. Common Stock (TLRY) is a publicly traded Healthcare sector company. As of May 21, 2026, TLRY trades at $5.41 with a market cap of $619.55M and a P/E ratio of 0.72. TLRY moved +3.93% today. Year to date, TLRY is -43.02%; over the trailing twelve months it is +19.45%. Its 52-week range spans $3.51 to $23.20. Analyst consensus is buy with an average price target of $7.98. Rallies surfaces TLRY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
TLRY financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TLRY recently traded at $5.41. Market cap is $619.55M. P/E ratio is 0.72. Revenue is $858.27M.
| Metric | Value |
|---|---|
| Price | $5.41 |
| Market Cap | $619.55M |
| P/E Ratio | 0.72 |
| EPS | $7.51 |
| Dividend Yield | 0.00% |
| 52-Week High | $23.20 |
| 52-Week Low | $3.51 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $858.27M |
| Net Income | $-1.34B |
| Gross Margin | 27.68% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $821.31M | $-2.18B | $-2.46 |
| 2024 | $788.94M | $-222.40M | $-0.33 |
| 2023 | $627.12M | $-1.44B | $-2.35 |
| 2022 | $628.37M | $-434.13M | $-0.90 |
6 analysts cover TLRY: 0 strong buy, 2 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.98.